Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: CALGB A091103 Principal Investigator: Van Tine, Brian
Title: Phase II Study of the Angiopoietin-1 and -2 Peptibody AMG 386 For the Treatment of Angiosarcoma
Phase: II Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
This phase II trial studies how well trebananib works in treating patients with advanced angiosarcoma that cannot be removed by surgery.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)